AstraZeneca Covid Vaccine Shows Promise in Early Human Testing

Jul.20 — A coronavirus vaccine the University of Oxford is developing with AstraZeneca Plc showed promising results in early human testing. The vaccine increased levels of both protective neutralizing antibodies and immune T-cells that target the virus, according to study organizers. Abigail Doolittle reports on “Bloomberg Markets.”